西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2013年
9期
82-83
,共2页
肝炎,丙型,慢性%茵陈蒿汤%干扰素%利巴韦林
肝炎,丙型,慢性%茵陳蒿湯%榦擾素%利巴韋林
간염,병형,만성%인진호탕%간우소%리파위림
hepatitis,C,chronic%YinChenHaoTang%interferon%ribavirin
目的：观察茵陈蒿汤加味联合干扰素、利巴韦林治疗慢性丙型肝炎的临床疗效。方法：将130例患者随机分为观察组、对照组各65例。2组均给予聚乙二醇干扰素a-2a及利巴韦林治疗，观察组同时给予茵陈蒿汤加味，水煎分服，1剂/d，连用48周。结果：显效率观察组为69.23%，对照组为50.77%，2组相比差异显著(P＜0.05)；总有效率观察组为92.31%，对照组为75.38%，2组相比差异显著(P＜0.05)。2组不良反应发生率相比，差异有统计学意义(P＜0.05)。结论：茵陈蒿汤加味联合干扰素、利巴韦林治疗慢性丙型肝炎临床疗效显著，不良反应低。
目的：觀察茵陳蒿湯加味聯閤榦擾素、利巴韋林治療慢性丙型肝炎的臨床療效。方法：將130例患者隨機分為觀察組、對照組各65例。2組均給予聚乙二醇榦擾素a-2a及利巴韋林治療，觀察組同時給予茵陳蒿湯加味，水煎分服，1劑/d，連用48週。結果：顯效率觀察組為69.23%，對照組為50.77%，2組相比差異顯著(P＜0.05)；總有效率觀察組為92.31%，對照組為75.38%，2組相比差異顯著(P＜0.05)。2組不良反應髮生率相比，差異有統計學意義(P＜0.05)。結論：茵陳蒿湯加味聯閤榦擾素、利巴韋林治療慢性丙型肝炎臨床療效顯著，不良反應低。
목적：관찰인진호탕가미연합간우소、리파위림치료만성병형간염적림상료효。방법：장130례환자수궤분위관찰조、대조조각65례。2조균급여취을이순간우소a-2a급리파위림치료，관찰조동시급여인진호탕가미，수전분복，1제/d，련용48주。결과：현효솔관찰조위69.23%，대조조위50.77%，2조상비차이현저(P＜0.05)；총유효솔관찰조위92.31%，대조조위75.38%，2조상비차이현저(P＜0.05)。2조불량반응발생솔상비，차이유통계학의의(P＜0.05)。결론：인진호탕가미연합간우소、리파위림치료만성병형간염림상료효현저，불량반응저。
Objective: To observe curative effects of modified YinChenHaoTang, interferon and ribavirin in treating chronic hepatitis C. Method:All 130 patients were randomized into the observation group and the control group. Both groups were given with pegylated-interferon α-2α and ribavirin, the observation oral modified YinChenHao Tang, water decocted, one dose per day, for 48 conservative weeks. Result:Effectual rate of the obser-vation group was 69.23%, higher than 50.77%of the control group with significant difference (P<0.05);total effec-tive rate of the observation group was 92.31%, superior to 75.38%of the control group with notable difference (P<0.05). The difference had statistical meaning in the incidence of adverse reaction (P<0.05). Conclusion: Modified YinChenHao Tang, interferon and ribavirin are effective in treating chronic hepatitis C with minor side-effects.
